• English
  • Español
  • Facebook
  • RSS
  • Twitter

Therapeutics Initiative

Independent Healthcare Evidence

  • TI
  • About Us
    • Oversight Committee
    • Executive Committee
    • Working Groups
      • Drug Assessment
      • Education
      • Therapeutics Letter
      • PharmacoEpidemiology
      • Quality Prescribing
      • Cochrane Hypertension
    • Members
    • TI Surveys
    • Questions & Answers
  • Therapeutics Letter
  • Our Evidence Reviews
  • Get Involved
  • Continuing Education
  • Contact Us
Home > Archives for peptic ulcer disease

[118] Trends in utilization of proton pump inhibitors in British Columbia

April 15, 2019 Therapeutics Letter 3 Comments

Download
Share

The first three Therapeutics Letters focused on complaints related to the upper gastrointestinal tract, a common presentation to the primary care physician.1-3 These Letters reviewed evidence about H2-blockers, eradication of Helicobacter pylori, and drugs used for gastroesophageal reflux. However, they also raised concerns about chronic acid suppression by daily dosing of omeprazole, the first … [Read more...]

[99] Comparative effectiveness of proton pump inhibitors

June 28, 2016 Therapeutics Letter 9 Comments

Download
Share

Six previous Therapeutics Letters reported information about the benefits and harms of different proton pump inhibitors (PPIs).1-6 These drugs work by irreversibly inhibiting gastric H+K+ ATPase (the proton pump) in the stomach. They inhibit both basal and stimulated acid secretion and are used in a number of clinical settings: gastroesophageal reflux disease (GERD), reflux esophagitis, peptic … [Read more...]

  • About Us
    • Oversight Committee
    • Questions & Answers
    • Executive Committee
    • Working Groups
      • Drug Assessment
      • Education
      • Therapeutics Letter
      • PharmacoEpidemiology
      • Quality Prescribing
      • Cochrane Hypertension
    • Members
    • TI Surveys
  • Therapeutics Letter
  • Our Evidence Reviews
  • Get Involved
  • Continuing Education
    • Best Evidence
  • Contact Us
  • Terms & Policies
    • Legal Information & Terms of Use
    • Privacy Policy
    • Acceptable Use Policy

Categories

  • News (111)
  • Therapeutics Letter (123)
  • Drug Assessments (36)
  • PharmacoEpidemiology (60)
  • Podcasts & Videos (18)

Recent Seminars

Dr. Joanna Moncrieff: Drug treatment for bipolar disorder and psychosis

Share

Methods Speaker Series 2019

Share

Twenty-Five Pearls from 25 years

Share

Therapeutics Initiative

Our mission is to provide physicians, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. Read more Donate

Contact

2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

Office: +1 604-822-0700
Fax: +1 604-822-0701

UBC logoISDB logo

Subscribe

Subscribe to receive email notifications about the Therapeutics Letter, upcoming educational events, and recent publications from the TI.

© 1994 - 2019 Therapeutics Initiative · Terms & Policies · TM